140 related articles for article (PubMed ID: 10137792)
21. Health spending projections through 2016: modest changes obscure part D's impact.
Poisal JA; Truffer C; Smith S; Sisko A; Cowan C; Keehan S; Dickensheets B
Health Aff (Millwood); 2007; 26(2):w242-53. PubMed ID: 17314105
[TBL] [Abstract][Full Text] [Related]
22. Medicaid policies for HIV-related prescription drugs.
Buchanan RJ; Smith SR
Health Care Financ Rev; 1994; 15(3):43-61. PubMed ID: 10137797
[TBL] [Abstract][Full Text] [Related]
23. National Health Spending In 2014: Faster Growth Driven By Coverage Expansion And Prescription Drug Spending.
Martin AB; Hartman M; Benson J; Catlin A;
Health Aff (Millwood); 2016 Jan; 35(1):150-60. PubMed ID: 26631494
[TBL] [Abstract][Full Text] [Related]
24. Drug utilization and cost in a Medicaid population: a simulation study of community vs. mail order pharmacy.
Valluri S; Seoane-Vazquez E; Rodriguez-Monguio R; Szeinbach SL
BMC Health Serv Res; 2007 Jul; 7():122. PubMed ID: 17663768
[TBL] [Abstract][Full Text] [Related]
25. Who cares what it costs to dispense a Medicaid prescription?
Lamphere-Thorpe JA; Johnston WP; Kilpatrick KE; Norwood GJ
Health Care Financ Rev; 1994; 15(3):9-24. PubMed ID: 10137800
[TBL] [Abstract][Full Text] [Related]
26. Alternative strategies for Medicare payment of outpatient prescription drugs--Part B and beyond.
Danzon PM; Wilensky GR; Means KE
Am J Manag Care; 2005 Mar; 11(3):173-80. PubMed ID: 15786856
[TBL] [Abstract][Full Text] [Related]
27. The effects of market structure and payment rate on the entry of private health plans into the Medicare market.
Frakt AB; Pizer SD; Feldman R
Inquiry; 2012; 49(1):15-36. PubMed ID: 22650015
[TBL] [Abstract][Full Text] [Related]
28. Medicare and drug pricing.
Iglehart JK
N Engl J Med; 2003 Apr; 348(16):1590-7. PubMed ID: 12700381
[No Abstract] [Full Text] [Related]
29. Trends in prescription drug expenditures by Medicaid enrollees.
Banthin JS; Miller GE
Med Care; 2006 May; 44(5 Suppl):I27-35. PubMed ID: 16625061
[TBL] [Abstract][Full Text] [Related]
30. Defining a future for fee-for-service Medicare.
Foote SB; Halaas GW
Health Aff (Millwood); 2006; 25(3):864-8. PubMed ID: 16684754
[TBL] [Abstract][Full Text] [Related]
31. Medicaid and indigent care issue brief: Medicaid: benefits and services: year end report-2003.
Johnson P
Issue Brief Health Policy Track Serv; 2003 Dec; ():1-33. PubMed ID: 14969254
[TBL] [Abstract][Full Text] [Related]
32. Will Ending the Medicaid Drug Rebate Cap Lower Drug Prices?
Rome BN; Kesselheim AS
JAMA Intern Med; 2021 Aug; 181(8):1034-1035. PubMed ID: 34180958
[No Abstract] [Full Text] [Related]
33. Reimbursement for partial hospitalization: a survey and policy implications.
Leibenluft E; Leibenluft RF
Am J Psychiatry; 1988 Dec; 145(12):1514-20. PubMed ID: 3143268
[TBL] [Abstract][Full Text] [Related]
34. Good research practices for measuring drug costs in cost-effectiveness analyses: Medicare, Medicaid and other US government payers perspectives: the ISPOR Drug Cost Task Force report--Part IV.
Mullins CD; Seal B; Seoane-Vazquez E; Sankaranarayanan J; Asche CV; Jayadevappa R; Lee WC; Romanus DK; Wang J; Hay JW; Smeeding J
Value Health; 2010; 13(1):18-24. PubMed ID: 19807903
[TBL] [Abstract][Full Text] [Related]
35. Medicaid and indigent care issue brief: Medicaid: services covered: year end report-2002.
Johnson P
Issue Brief Health Policy Track Serv; 2002 Dec; ():1-21. PubMed ID: 12877158
[TBL] [Abstract][Full Text] [Related]
36. Can price and regulatory controls replace free market competition in the drug industry?
Buc NL; Levitt GM
Healthspan; 1993 Nov; 10(10):30-2. PubMed ID: 10130839
[No Abstract] [Full Text] [Related]
37. Paying more for primary care: can it help bend the Medicare cost curve?
Reschovsky JD; Ghosh A; Stewart K; Chollet D
Issue Brief (Commonw Fund); 2012 Mar; 5():1-14, 1-12. PubMed ID: 22439245
[TBL] [Abstract][Full Text] [Related]
38. Prescription drug prices in Canada.
Gross D
Issue Brief (Public Policy Inst (Am Assoc Retired Pers)); 2003 Jun; (IB62):1-22. PubMed ID: 12807123
[No Abstract] [Full Text] [Related]
39. Medicare and prescription drugs.
Iglehart JK
N Engl J Med; 2001 Mar; 344(13):1010-5. PubMed ID: 11274630
[No Abstract] [Full Text] [Related]
40. Health spending by state: new estimates for policy making.
Levit KR; Lazenby HC; Cowan CA; Letsch SW
Health Aff (Millwood); 1993; 12(3):7-26. PubMed ID: 8244248
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
